Your browser is no longer supported. Please, upgrade your browser.
BioDelivery Sciences International, Inc.
Index- P/E12.41 EPS (ttm)0.32 Insider Own1.60% Shs Outstand98.79M Perf Week1.26%
Market Cap388.49M Forward P/E9.71 EPS next Y0.41 Insider Trans25.56% Shs Float96.02M Perf Month-1.96%
Income33.90M PEG0.50 EPS next Q0.06 Inst Own67.20% Short Float2.15% Perf Quarter9.26%
Sales164.10M P/S2.37 EPS this Y233.10% Inst Trans-0.27% Short Ratio2.96 Perf Half Y20.06%
Book/sh1.15 P/B3.49 EPS next Y60.70% ROA14.10% Target Price6.88 Perf Year6.65%
Cash/sh1.24 P/C3.24 EPS next 5Y25.00% ROE31.70% 52W Range3.04 - 4.99 Perf YTD-4.52%
Dividend- P/FCF- EPS past 5Y18.50% ROI17.50% 52W High-18.54% Beta0.70
Dividend %- Quick Ratio2.80 Sales past 5Y26.50% Gross Margin85.50% 52W Low33.72% ATR0.16
Employees176 Current Ratio3.10 Sales Q/Q13.10% Oper. Margin26.10% RSI (14)58.69 Volatility2.64% 4.25%
OptionableYes Debt/Eq0.69 EPS Q/Q720.20% Profit Margin20.60% Rel Volume0.41 Prev Close4.01
ShortableYes LT Debt/Eq0.64 EarningsAug 04 BMO Payout0.00% Avg Volume697.31K Price4.07
Recom1.90 SMA206.40% SMA506.34% SMA2006.60% Volume265,899 Change1.37%
Apr-22-20Initiated Northland Capital Outperform $9
Jan-09-20Initiated Piper Sandler Overweight $9
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
Oct-03-21 09:09AM  
Sep-30-21 08:00AM  
Sep-27-21 02:01PM  
Sep-21-21 11:36AM  
Sep-14-21 12:51PM  
Sep-09-21 08:30AM  
Sep-07-21 09:28AM  
Sep-03-21 11:31AM  
Aug-16-21 08:00AM  
Aug-10-21 10:45AM  
Aug-04-21 07:00PM  
Jul-28-21 03:03PM  
Jul-22-21 08:00AM  
Jul-13-21 06:12AM  
Jun-20-21 03:46AM  
Jun-08-21 03:16PM  
May-06-21 10:00PM  
Apr-29-21 05:00PM  
Apr-20-21 08:00AM  
Apr-09-21 11:30AM  
Mar-30-21 07:22AM  
Mar-22-21 01:33AM  
Mar-10-21 03:30PM  
Mar-03-21 12:30PM  
Feb-17-21 08:00AM  
Feb-11-21 08:00AM  
Feb-08-21 10:11AM  
Feb-05-21 01:07AM  
Jan-15-21 09:00AM  
Dec-21-20 11:54PM  
Dec-19-20 06:11PM  
Dec-05-20 11:31AM  
Nov-20-20 08:30AM  
Nov-17-20 09:40AM  
Nov-11-20 08:30AM  
Nov-07-20 08:02AM  
Nov-06-20 06:00AM  
Nov-05-20 07:00PM  
Nov-04-20 05:31PM  
Oct-23-20 08:00AM  
Sep-28-20 10:41AM  
Sep-24-20 10:46AM  
Sep-14-20 12:06PM  
Sep-11-20 08:00AM  
Sep-04-20 11:31AM  
Sep-03-20 08:00AM  
Aug-10-20 09:08AM  
Aug-06-20 10:05AM  
Aug-05-20 09:05AM  
Jul-29-20 12:33PM  
Jul-27-20 04:01PM  
Jul-12-20 07:39PM  
Jun-10-20 05:44PM  
Jun-09-20 11:38PM  
Jun-06-20 11:31AM  
May-29-20 12:17PM  
May-26-20 10:43AM  
May-11-20 08:30AM  
May-09-20 05:01PM  
May-08-20 10:52AM  
May-07-20 06:35PM  
Apr-30-20 12:34PM  
Apr-28-20 08:00AM  
Apr-27-20 12:31PM  
Mar-24-20 10:02PM  
Mar-14-20 08:51AM  
Mar-13-20 09:29AM  
Mar-12-20 08:55PM  
Mar-09-20 08:00AM  
Mar-05-20 12:30PM  
Feb-27-20 05:15PM  
Feb-24-20 02:59PM  
Feb-20-20 08:00AM  
Feb-06-20 10:44AM  
Jan-30-20 10:15AM  
Jan-29-20 10:06AM  
Jan-27-20 05:20PM  
Jan-13-20 08:30AM  
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh VanilaDirectorAug 23Option Exercise0.004,000022,834Aug 25 04:39 PM
Sirgo Mark ADirectorAug 23Option Exercise0.004,00001,114,595Aug 25 04:37 PM
KOTLER KEVINDirectorAug 10Option Exercise2.9315,00043,9504,700,689Aug 10 06:19 PM
Singh VanilaDirectorAug 06Option Exercise0.006,750018,834Aug 10 06:26 PM
Sirgo Mark ADirectorAug 06Option Exercise0.004,00001,110,595Aug 10 06:24 PM
Bailey Jeffrey AllenChief Executive OfficerAug 06Option Exercise0.005,567046,467Aug 10 06:23 PM
Watson W. MarkDirectorAug 06Option Exercise0.0030,000082,979Aug 10 06:21 PM
KOTLER KEVINDirectorAug 06Option Exercise0.0030,00004,685,689Aug 10 06:19 PM
Greenleaf PeterDirectorAug 06Option Exercise0.0035,000094,788Aug 10 06:17 PM
Davis Todd CDirectorAug 06Option Exercise0.0030,0000244,523Aug 10 06:15 PM
KOTLER KEVINDirectorMay 13Buy3.2550,000162,5004,655,689May 13 05:38 PM
Sirgo Mark ADirectorMay 13Buy3.163,0009,4801,106,595May 13 05:36 PM
Sirgo Mark ADirectorMay 12Buy3.245,00016,2001,103,595May 13 05:36 PM
KOTLER KEVINDirectorMay 12Buy3.24100,000324,0004,605,689May 13 05:38 PM
KOTLER KEVINDirectorMay 11Buy3.16150,000474,0004,505,689May 13 05:38 PM
Sirgo Mark ADirectorMay 11Buy3.167,50023,7001,098,595May 13 05:36 PM
Plesha Scott M.See RemarksMar 12Option Exercise0.0020,8340299,874Mar 16 04:57 PM
Bailey Jeffrey AllenChief Executive OfficerMar 09Option Exercise0.005,333040,900Mar 11 04:14 PM
Vollins JamesSee RemarksFeb 08Sale4.163,83315,9450Feb 08 05:46 PM
Vollins JamesSee RemarksFeb 04Sale3.978,30332,9633,833Feb 08 05:46 PM
Vollins JamesSee RemarksFeb 01Option Exercise0.003,833012,136Feb 02 05:59 PM
Plesha Scott M.See RemarksFeb 01Option Exercise0.0013,3330258,206Feb 02 06:17 PM
Smith Thomas BChief Medical OfficerFeb 01Option Exercise0.007,667019,954Feb 02 05:55 PM
Coelho Mary TheresaSee RemarksFeb 01Sale3.873,46013,39030,619Feb 02 07:12 PM
Coelho Mary TheresaSee RemarksJan 29Option Exercise0.0010,190034,079Feb 02 07:12 PM
Smith Thomas BChief Medical OfficerJan 29Option Exercise0.007,548012,287Feb 02 05:55 PM
Plesha Scott M.See RemarksJan 29Option Exercise0.0010,8700244,873Feb 02 06:17 PM
Vollins JamesSee RemarksJan 29Option Exercise0.008,30308,303Feb 02 05:59 PM
Coelho Mary TheresaSee RemarksJan 19Sale4.326,46227,91623,889Jan 20 04:30 PM
Coelho Mary TheresaSee RemarksJan 15Option Exercise0.0018,333030,351Jan 20 04:30 PM
Vollins JamesSee RemarksDec 16Option Exercise3.469,50532,8879,505Dec 16 04:39 PM
Vollins JamesSee RemarksDec 16Sale4.489,50542,5820Dec 16 04:39 PM
Bailey Jeffrey AllenChief Executive OfficerDec 15Sale4.3510,00043,50035,567Dec 16 04:41 PM
Vollins JamesSee RemarksDec 14Option Exercise3.4620,32070,30720,320Dec 16 04:39 PM
Vollins JamesSee RemarksDec 14Sale4.4620,32090,6270Dec 16 04:39 PM
Singh VanilaDirectorNov 23Option Exercise0.005,333012,084Nov 27 04:16 PM
Bailey Jeffrey AllenChief Executive OfficerNov 04Option Exercise0.0040,000045,567Nov 06 05:21 PM